From Novel Science to Bedside Reality: How Health Systems Must Scale to a New Care Delivery Model for Cell and Gene Therapy

The cell and gene therapy pipeline is no longer a distant possibility. It is arriving now, and health systems have a narrowing window to prepare. With more than 35 Food and Drug Administration-approved Cell and Gene Therapies (CGT) and a pipeline that continues to expand into larger patient populations and new therapeutic areas, the CGT […] The post From Novel Science to Bedside Reality: How Health Systems Must Scale to a New Care Delivery Model for Cell and Gene Therapy appeared first on...